Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1022 of 5804
-
New RNA test could spot brain tumors without surgery
Diagnosis Recruiting nowDiffuse gliomas are among the most common tumors of the central nervous system, with high morbidity and mortality and very limited therapeutic possibilities. The diffuse glioma are characterized by significant variability in terms of age at diagnosis, histological and molecular f…
Phase: NA • Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle • Aim: Diagnosis
Last updated Jun 27, 2026 13:07 UTC
-
New combo therapy targets Hard-to-Treat prostate cancer
Disease control Not yet recruitingThis is a Phase I, open-label, single-center study evaluating the safety, tolerability, and recommended Phase II dose of docetaxel when combined with a fixed dose of 177-Lutetium-PSMA-I\&T in chemotherapy-naïve patients with metastatic castration-resistant prostate cancer (mCRPC)…
Phase: PHASE1 • Sponsor: Instituto do Cancer do Estado de São Paulo • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New tablet program aims to curb teen suicide in rural ERs
Knowledge-focused Not yet recruitingThe goal of this observational study is to determine whether implementing a culturally sensitive, tablet-based safety planning program called Plan \& Protect (P\&P) within rural emergency departments can improve home safety and reduce suicide risk in adolescents presenting with s…
Phase: NA • Sponsor: Dartmouth-Hitchcock Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC
-
Could a higher drug dose help sickle cell patients get stem cell transplants?
Disease control Not yet recruitingThe objective of this study is to demonstrate whether high-dose plerixafor can effectively mobilize hematopoietic stem cells in patients with sickle cell disease. It will also learn about the safety of this drug in higher doses in these patients. The main questions it aims to ans…
Phase: PHASE1, PHASE2 • Sponsor: Hospital Israelita Albert Einstein • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Can a phone app help beat opioid addiction? new trial aims to find out
Disease control Not yet recruitingThis trial will assess effects of enrollment in a comprehensive telehealth platform, RecoveryPad (RP), in adults with moderate or severe opioid use disorder.
Phase: NA • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New study aims to reduce DKA risk for type 1 diabetes patients using SGLT2 inhibitors
Disease control Not yet recruitingThe purpose of this research is to see how well a special education plan using continuous ketone monitoring (DGK) works to lower the risk of a condition called diabetic ketoacidosis (DKA) in people with type 1 diabetes (T1D) taking SGLT2 inhibitors (a type of medication commonly …
Phase: PHASE2 • Sponsor: AdventHealth Translational Research Institute • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
New hope for ulcerative colitis patients who failed biologics?
Disease control Not yet recruitingThe primary objective of this trial is to evaluate the clinical efficacy of ATH-063 in participants with biologic/advanced therapy relapsed/refractory moderately to severely active UC.
Phase: PHASE2 • Sponsor: Athos Therapeutics Inc • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Stem cell shot into ovaries aims to tame perimenopause symptoms
Disease control ENROLLING_BY_INVITATIONThis observational study examines the safety and effects of injecting Muse cells (a type of naturally occurring stem like cells found in adult tissues such as fat or bone marrow) directly into the ovaries of women aged 28 to 70 who are going through peri-menopause. Perimenopause…
Sponsor: Healing Hope International • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New cocktail aims to shrink sarcomas: bevacizumab joins chemo in phase 2 trial
Disease control Not yet recruitingArm1- bevacizumab (Onbevzi) at a dose of 15 mg/kg administered as a 30-minute intravenous infusion on Day 1 of each 21-day cycle, followed by intravenous infusion of gemcitabine and docetaxel in sequence. On Day 8 of each cycle, gemcitabine and docetaxel will be administered as a…
Phase: PHASE2 • Sponsor: Yonsei University • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Could a daily cannabinoid pill tame tourette tics?
Symptom relief Not yet recruitingTo evaluate the efficacy, safety and tolerability of the cannabinoid-based medication SCI-110 compared to placebo in subjects with Tourette syndrome.
Phase: PHASE2 • Sponsor: Neurothera Labs Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Could a gentle brain zap help kids with cerebral palsy move better?
Disease control Not yet recruiting* To determine the effects of tDCS in conjunction with task-oriented training (TOT) and virtual reality (VR) as compared with sham stimulation and conventional physiotherapy on cortical activity and muscle synergy. * To determine the retention effects of tDCS in conjunction with …
Phase: NA • Sponsor: Riphah International University • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
New drug targets Hard-to-Treat cancers with missing gene
Disease control Not yet recruitingThis is a phase I, open-label, first-in-human study of CS08399, comprising two phases: dose escalation (including single-dose and multiple-dose) and cohort expansion. The primary objectives of this study are to evaluate the safety, tolerability and pharmacokinetic (PK) characteri…
Phase: PHASE1 • Sponsor: Chipscreen Biosciences, Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Nerve-Cutting surgery could replace costly pumps for spasticity
Disease control Not yet recruitingThe investigators will investigate the selective dorsal rhizotomy in post traumatic brain and spinal cord injury induced spasticity to evaluate the efficacy of this procedure in reducing the tone of the spastic muscle groups. Selective dorsal rhizotomy is well established effect…
Phase: NA • Sponsor: Assiut University • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New drug SKB118 aims to shrink Hard-to-Treat tumors
Disease control Not yet recruitingThis is a phase 1/2 clinical study to evaluate the safety and efficacy of SKB118 in participants with advanced solid tumors. The study includes a dose escalation stage, a dose expansion stage, and a indication expansion stage.
Phase: PHASE1, PHASE2 • Sponsor: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New drug AB801 aims to boost chemo and immunotherapy in tough cancers
Disease control Not yet recruitingThis phase I trial tests the safety, side effects, best dose and effectiveness of AB801 in combination with chemotherapy and immunotherapy in treating patients with cholangiocarcinoma or pancreatic adenocarcinoma that may be removed by surgery (borderline resectable), that has sp…
Phase: PHASE1 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
Smart oxygen device could help preterm babies breathe easier
Disease control Not yet recruitingThis randomised controlled trial aims to investigate the effectiveness of closed-loop automated oxygen control (CLAC) in preterm infants receiving non-invasive respiratory support and determine if it reduces the duration of supplementary oxygen treatment and improves achievement …
Phase: NA • Sponsor: King's College Hospital NHS Trust • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
New biopsy method may spare breast cancer patients from unnecessary surgery
Diagnosis Not yet recruitingNeoadjuvant chemotherapy is widely used in the treatment of locally advanced breast cancer or in early stages of triple-negative or HER2 overexpressing tumors. Pathological complete response (pCR) to neoadjuvant chemotherapy is associated with better clinical outcomes. However, c…
Phase: NA • Sponsor: Instituto do Cancer do Estado de São Paulo • Aim: Diagnosis
Last updated Jun 27, 2026 13:06 UTC
-
Glucose sensor reveals your personal 'Blood sugar danger Zone' – and a simple fix
Disease control Recruiting nowThis study will test whether glucose sensor data can be used to identify the time of day when adults with prediabetes are most likely to have high blood sugar after meals. Participants will first wear a continuous glucose monitor and wrist activity monitor and record meal times f…
Phase: NA • Sponsor: Shifa International Hospital • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
Could a new anesthetic keep your mind sharper after a procedure?
Disease control OngoingThis study aims to explore the effect of ciprofol on the postoperative cognitive function of inpatients undergoing gastrointestinal endoscopy examination, to compare the anesthetic effects and differences in adverse reactions of propofol and ciprofol in gastrointestinal endoscopy…
Phase: PHASE4 • Sponsor: The Second Affiliated Hospital of Chongqing Medical University • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Blood-Based injection may offer new hope for chronic back pain without burning nerves
Symptom relief Not yet recruitingThe first clinical research effort under this initiative is a pilot randomized controlled trial comparing intra-periarticular lumbar facet platelet-rich plasma (PRP) injection to standard-of-care medial branch radiofrequency ablation (RFA) for chronic lumbar facet-mediated pain. …
Phase: NA • Sponsor: The New England Baptist Hospital • Aim: Symptom relief
Last updated Jul 11, 2026 00:00 UTC